Viking Therapeutics stock skidded Wednesday despite the "encouraging" speed with which the company enrolled patients in an obesity study.
Goldman Sachs analyst Ben Andrews initiated coverage with a Buy rating on Viking Holdings Ltd (VIK – Research Report) today and set a price ...
LOS ANGELES--(BUSINESS WIRE)--Viking® (www.viking.com) (NYSE: VIK) today announced it has taken delivery of the Viking Nerthus, the company’s newest Viking Longship®. The delivery took place ...